ProfileGDS4459 / ENSG00000197162
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 30% 36% 28% 52% 48% 57% 36% 37% 45% 42% 40% 37% 43% 27% 41% 70% 47% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.7730
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.9636
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.4128
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.5752
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.3148
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.6557
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.8436
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.8437
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.1645
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.142
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.9640
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.8437
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.1643
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.6927
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.9841
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.1670
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.2747